Wei‐Juin Su
Impact in
- Pharmacology top 0.5%
- Drug-Induced Hepatotoxicity and Protection
- Pharmacogenetics and Drug Metabolism
- Infectious Diseases top 2%
- Tuberculosis Research and Epidemiology
Papers in
-
- Tuberculosis Research and Epidemiology 40
- Surgery 28
- Infectious Diseases and Tuberculosis 12
- Diagnosis and treatment of tuberculosis 11
- Co-authors
- Full‐Young Chang (3 shared papers)Shou‐Dong Lee (3 shared papers)Yi‐Shin Huang (3 shared papers)Herng‐Der Chern (2 shared papers)Jia‐Yih Feng (32 shared papers)Sheng‐Wei Pan (31 shared papers)Vincent Yi‐Fong Su (17 shared papers)Chi‐Huei Chiang (4 shared papers)
- Journals
- Medicine (4 papers)CHEST Journal (4 papers)PLoS ONE (3 papers)Lung Cancer (3 papers)Diagnostic Microbiology and Infectious Disease (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Wei‐Juin Su
95 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 119
- Pharmacology 616
- Infectious Diseases 830
- Epidemiology 565
- Oncology 301
- Hepatology 76
Countries citing papers authored by Wei‐Juin Su
This map shows the geographic impact of Wei‐Juin Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Juin Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Juin Su more than expected).
Fields of papers citing papers by Wei‐Juin Su
This network shows the impact of papers produced by Wei‐Juin Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Juin Su. The network helps show where Wei‐Juin Su may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei‐Juin Su, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 323 | |
| 2 | 2003 | 312 | |
| 3 | 2007 | 162 | |
| 4 | 2014 | 117 | |
| 5 | 2012 | 66 | |
| 6 | 2017 | 62 | |
| 7 | 2016 | 57 | |
| 8 | 2017 | 55 | |
| 9 | 2018 | 55 | |
| 10 | 2011 | 50 | |
| 11 | 2017 | 44 | |
| 12 | 2014 | 41 | |
| 13 | 2010 | 40 | |
| 14 | 1992 | 39 | |
| 15 | 2016 | 38 | |
| 16 | 2004 | 34 | |
| 17 | 2011 | 32 | |
| 18 | 2015 | 31 | |
| 19 | 2005 | 31 | |
| 20 | 2020 | 31 |
About Wei‐Juin Su
Wei‐Juin Su is a scholar working on Infectious Diseases, Surgery, Epidemiology, Pulmonary and Respiratory Medicine and Immunology, having authored 100 papers that have together received 2.5k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (40 papers), Mycobacterium research and diagnosis (15 papers), Infectious Diseases and Tuberculosis (12 papers), Diagnosis and treatment of tuberculosis (11 papers), Lung Cancer Treatments and Mutations (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (4 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). The work is most often cited by research in Pharmacology (616 citations), Infectious Diseases (830 citations), Epidemiology (565 citations), Oncology (301 citations) and Hepatology (76 citations). Wei‐Juin Su has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Full‐Young Chang, Shou‐Dong Lee, Yi‐Shin Huang, Herng‐Der Chern, Jia‐Yih Feng, Sheng‐Wei Pan, Vincent Yi‐Fong Su, Chi‐Huei Chiang, Shi-Chuan Chang and Kun‐Ta Chou. Their work appears in journals such as Medicine, CHEST Journal, PLoS ONE, Lung Cancer and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.